A MONOCLONAL ANTIBODY TO CD44 FOR USE IN THE TREATMENT OF HEAD AND NECK SQUAMOUS CELL CARCINOMA

• 收藏
• 分享

专利权人:

F. HOFFMANN-LA ROCHE AG;UNIVERSITY OF MIAMI

发明人:

DA CRUZ, LUIS A

申请号：

NZ60007911

公开号：

NZ600079A

申请日:

2011.02.02

申请国别(地区):

NZ

年份:

2013

代理人:

摘要：

Patent No. 600079 Disclosed is the use of a monoclonal anti-CD44 antibody or antigen biding fragment thereof, for the manufacture of a medicament for the treatment of a head and neck squamous cell carcinoma (HNSCC) in a mammal, wherein said HNSCC is characterized by the expression of CD44.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/